Mer­ck­'s PD-1xVEGF part­ner LaNo­va gets snapped up for $951M

One of Mer­ck’s most promi­nent part­ners just got ac­quired.

LaNo­va Med­i­cines is be­ing bought out by Hong Kong-based Sino Bio­phar­ma­ceu­ti­cal for $950.9 mil­lion, Sino …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER